131
Views
62
CrossRef citations to date
0
Altmetric
Original Research

Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer

, , , , , , , , & show all
Pages 5313-5330 | Published online: 26 Jul 2017

References

  • SunYZhengYRanHSuperparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablationBiomaterials201233245854586422617321
  • ChenTShukoorMIWangRSmart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imagingACS Nano20115107866787321888350
  • KooOMRubinsteinIOnyukselHRole of nanotechnology in targeted drug delivery and imaging: a concise reviewNanomedicine20051319321217292079
  • AravindANairRRaveendranSAptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapyJ Magn Magn Mater2013344344116123
  • YangHDengLLiTMultifunctional PLGA nanobubbles as theranostic agents: combining doxorubicin and P-gp siRNA co-delivery into human breast cancer cells and ultrasound cellular imagingJ Biomed Nanotechnol201511122124213626510307
  • DengLLiLYangHDevelopment and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cellsJ Nanosci Nanotechnol20141442947295424734715
  • YangHLiKLiuYLiuZMiyoshiHPoly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effectJ Nanosci Nanotechnol20099128228719441308
  • MaJShenMXuCSSunYDuanYRDuLFBiodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitroOncotarget2016748800088001827835907
  • KimCQinRXuJSWangLVXuRMultifunctional microbubbles and nanobubbles for photoacoustic and ultrasound imagingJ Biomed Opt201015101051020210423
  • MakadiaHKSiegelSJPoly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers (Basel)2011331377139722577513
  • ZhangXZhengYWangZMethotrexate-loaded PLGA nanobubbles for ultrasound imaging and synergistic targeted therapy of residual tumor during HIFU ablationBiomaterials201435195148516124680663
  • RapoportNGaoZKennedyAMultifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapyJ Natl Cancer Inst200799141095110617623798
  • SantraSKaittanisCSantiestebanOJPerezJMCell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapyJ Am Chem Soc201113341166801668821910482
  • FanZFuPPYuHRayPCTheranostic nanomedicine for cancer detection and treatmentJ Food Drug Anal201422131724673900
  • CabralHNishiyamaNKataokaKSupramolecular nanodevices: from design validation to theranostic nanomedicineAcc Chem Res20114410999100821755933
  • KelkarSSReinekeTMTheranostics: combining imaging and therapyBioconjug Chem201122101879190321830812
  • SunTZhangYSPangBHyunDCYangMXiaYEngineered nanoparticles for drug delivery in cancer therapyAngew Chem Int Ed Engl20145346123201236425294565
  • DuJZMaoCQYuanYYYangXZWangJTumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapyBiotechnol Adv201432478980323933109
  • MuthuMSLeongDTMeiLFengSSNanotheranostics – application and further development of nanomedicine strategies for advanced theranosticsTheranostics20144666067724723986
  • YangTZhaoPRongZAnti-tumor efficiency of lipid-coated cisplatin nanoparticles co-loaded with microRNA-375Theranostics20166114215426722380
  • HongCANamYSFunctional nanostructures for effective delivery of small interfering RNA therapeuticsTheranostics20144121211123225285170
  • ChoHSDongZPaulettiGMFluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatmentACS Nano2010495398540420707381
  • DunneMCorriganIRamtoolaZInfluence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particlesBiomaterials200021161659166810905407
  • GraysonACCimaMJLangerRSize and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performanceBiomaterials200526142137214515576189
  • AravindAVargheseSHVeeranarayananSAptamer-labeled PLGA nanoparticles for targeting cancer cellsCancer Nanotechnol201231–611226069492
  • KoziaraJMLockmanPRAllenDDMumperRJPaclitaxel nanoparticles for the potential treatment of brain tumorsJ Control Release200499225926915380635
  • LiangHFChenCTChenSCPaclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancerBiomaterials20062792051205916307794
  • FaulhammerDEschgfallerBStarkSBiostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQRNA200410351652714970396
  • JeongSLeeHKKimMYUse of RNA aptamers for the modulation of cancer cell signalingMethods Mol Biol200954236337719565913
  • HuangZPeiWJayaseelanSShiHNiuLRNA aptamers selected against the GluR2 glutamate receptor channelBiochemistry20074644126481265517929944
  • FanXGuoYWangLXiongXZhuLFangKDiagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubblesInt J Nanomedicine2016113939395027574424
  • FarokhzadOCJonSKhademhosseiniATranTNLavanDALangerRNanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cellsCancer Res200464217668767215520166
  • RistauBTO’KeefeDSBacichDJThe prostate-specific membrane antigen: lessons and current clinical implications from 20 years of researchUrol Oncol201432327227924321253
  • LupoldSEHickeBJLinYCoffeyDSIdentification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigenCancer Res200262144029403312124337
  • WangCHKangSTLeeYHLuoYLHuangYFYehCKAptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosisBiomaterials20123361939194722142768
  • XingLShiQZhengKUltrasound-mediated microbubble destruction (UMMD) facilitates the delivery of CA19-9 targeted and paclitaxel loaded mPEG-PLGA-PLL nanoparticles in pancreatic cancerTheranostics20166101573158727446491
  • WangYLiuPQiuLToxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in miceBiomaterials201334164068407723480957
  • LiuPQinLWangQcRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancerBiomaterials201233286739674722763223
  • YinPWangYQiuYBufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activityInt J Nanomedicine201273961396922888239
  • WangHZhaoYWuYEnhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesBiomaterials201132328281829021807411